LD-2 disclosure · 1st Quarter - Report
ALKERMES, INC.
Client
- Name
- ALKERMES, INC.
- Description
- biopharmaceutical company
- Location
- Massachusetts · United States of America
Registrant
- Description
- Government Affairs Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Implementation of the Comprehensive Addiction and Recovery Act of 2016, P.L.114-198. Issues related to the opioid and mental illness epidemic, Commerce, State, Justice, and Labor, Health and Human Services Appropriations.
LobbyistsGARY PALMQUIST · ALEX DELPIZZO
Covered position (GARY PALMQUIST): Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen
Covered position (ALEX DELPIZZO): Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
LobbyistsGARY PALMQUIST · ALEX DELPIZZO
TargetedSENATE · HOUSE OF REPRESENTATIVES